The AJMC® Diabetes compendium is a comprehensive resource for clinical news and expert insights for the chronic condition.
February 5th 2026
Across 39 patients in 2 cohorts, rapid microbe reduction, high wound closure, restored warmth and sensation, and avoided amputations were observed.
Advancing Immunotherapy in Endometrial Cancer: A Managed Care Perspective on Personalized Care
1.5 Credits / Gynecologic Cancer, Health Equity, Diversity & Inclusion, Oncology, Women's Health
View More
Payment for Pharmacist Services: 2025 Update
1.0 Credit / General Pharmacy, Health Equity, Diversity & Inclusion, Law
View More
Understanding Antipsychotic Drug Mechanisms Helps Predict Side Effects-and How to Respond
September 11th 2015Peter Weiden, MD, says that psychiatrists have greater ability to address side effects from antipsychotics than they did 10 years ago. It's essential that clinicians take patient concerns seriously, because when they don't patients may react by stopping their medication.
Read More
Surgeon General Urges Americans to Walk More to Combat Chronic Disease
September 9th 2015Research shows that about 150 minutes per week of moderate exercise, such as walking, can have significant health benefits. Changes in American lifestyles in recent decades have made limited the amount of time spent walking, with unfortunate results.
Read More
DPP-4 Inhibitors Subject of FDA Safety Warning
September 7th 2015FDA has warned that the drug class dipeptidyl peptidase-4 (DPP-4) inhibitors may cause joint pain that can be severe and disabling. In a statement, the FDA said said it had issued a "warning and precaution" to all labels in this drug class.
Read More
Dr Robert Gabbay Describes Participation Levels in Diabetes Clinical Trials
September 2nd 2015While it's exciting to see more and more physicians wanting to participate in clinical, they need a little background, support, and infrastructure to do so, said Robert Gabbay, MD, PhD, chief medical officer and senior vice president of Joslin Diabetes Center.
Watch
For Now, Pharmacy Managers Just Say No to High-Cost PCSK9 Cholesterol Drugs
August 28th 2015Both ExpressScripts and CVS Health say the new class of cholesterol-fighting drugs will be generally unavailable until their P&T committees complete evaluations, and negotiations for discounts or exclusive deals occur.
Read More
Repatha, Amgen's PCSK9 Competitor, Gains FDA Approval
August 27th 2015The approval of evolocumab (Repatha) creates competition in the new class of PCSK9 cholesterol-fighting therapies and managed care plans and pharmacy benefit managers are expected to take full advantage to hold down costs.
Read More
CVS Unveils Deals to Expand Telehealth Services for Consumers
August 27th 2015Both surveys and peer-reviewed research show patients like telehealth services. CVS' announcement comes after a successful pilot program showed a collaboration of telehealth and the retail clinics produced good results for patients.
Read More
Dr Andrew Pumerantz Discusses Lifestyle Management Challenges Facing Patients With Diabetes
August 21st 2015Patients with diabetes whose traditions and culture includes celebrations with food should not take a negative approach to lifestyle management and dietary restrictions, according to Andrew Pumerantz, DO, FACP, of the Western Diabetes Institute.
Watch
Kerri Sparling Sees Positive Changes for Patient Engagement in Diabetes Care
August 21st 2015Patients with diabetes are entering a new era in which they can take charge of their own health and medical needs and come ready with questions and ideas to manage their disease, said Kerri Sparling, writer/editor of patient diabetes blog Six Until Me.
Watch
Healthcare Access a Focus of Alabama Tax Reforms
August 21st 2015Governor Robert Bentley is calling out fellow Republicans in Alabama's legislature and asking what they would cut if they fail to pass his $300 million tax proposal. His state has some of the nation's highest rates of diabetes and obesity.
Read More
Jardiance: Diabetes Drug Hits "Holy Grail" of Cutting Heart Attack, Stroke Risk in Trial
August 20th 2015Results for the cardiovascular outcomes trial on the SGLT2 inhibitor mark the first time one of the newer diabetes drugs has produced benefits since the FDA began looking closely at these effects. Full data will be presented next month at the European Association for the Study of Diabetes.
Read More
Intarcia Says Phase 3 Results Show Better Control Than Januvia for Type 2 Diabetes
August 19th 2015The ITCA 650 device, which delivers tiny doses of exenatide, could be a game changer in solving the problem of medication adherence. An application for FDA approval is expected in the first half of 2016.
Read More
Compared with traditional Medicare, relative resource use for those with diabetes or cardiovascular disease is lower in Medicare Advantage, while quality of care is higher.
Read More
Differential Impact of Mental Health Multimorbidity on Healthcare Costs in Diabetes
Assessment of prevalence and specific costs associated with discrete multimorbid mental health disease clusters in adults with diabetes.
Read More